164 related articles for article (PubMed ID: 29305959)
1. Enhanced in vitro activity of tigecycline in the presence of chelating agents.
Deitchman AN; Singh RSP; Rand KH; Derendorf H
Int J Antimicrob Agents; 2018 May; 51(5):799-802. PubMed ID: 29305959
[TBL] [Abstract][Full Text] [Related]
2. Tandem amplification of a plasmid-borne tet(A) variant gene confers tigecycline resistance in Escherichia coli.
Zou C; Xu C; Yu R; Shan X; Schwarz S; Li D; Du XD
J Antimicrob Chemother; 2024 Jun; 79(6):1294-1302. PubMed ID: 38574003
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
4. Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance.
Linkevicius M; Sandegren L; Andersson DI
Antimicrob Agents Chemother; 2016 Feb; 60(2):789-96. PubMed ID: 26596936
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S; Datta S; Viswanathan R; Singh AK; Basu S
J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
Mohamed NM; Youssef AA
Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance.
Li P; Wei Y; Li G; Cheng H; Xu Z; Yu Z; Deng Q; Shi Y
Microb Pathog; 2020 Dec; 149():104502. PubMed ID: 32947016
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
[TBL] [Abstract][Full Text] [Related]
10. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
[TBL] [Abstract][Full Text] [Related]
11. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
Fluit AC; Florijn A; Verhoef J; Milatovic D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
[TBL] [Abstract][Full Text] [Related]
12. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
[TBL] [Abstract][Full Text] [Related]
13. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
[TBL] [Abstract][Full Text] [Related]
14. Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
Li X; Mu X; Yang Y; Hua X; Yang Q; Wang N; Du X; Ruan Z; Shen X; Yu Y
Int J Antimicrob Agents; 2016 Apr; 47(4):324-7. PubMed ID: 26944192
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
[TBL] [Abstract][Full Text] [Related]
16. Tigecycline Susceptibility of Klebsiella pneumoniae Complex and Escherichia coli Isolates from Companion Animals: The Prevalence of Tigecycline-Nonsusceptible K. pneumoniae Complex, Including Internationally Expanding Human Pathogenic Lineages.
Sato T; Harada K; Usui M; Tsuyuki Y; Shiraishi T; Tamura Y; Yokota SI
Microb Drug Resist; 2018; 24(6):860-867. PubMed ID: 29232167
[TBL] [Abstract][Full Text] [Related]
17. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
[TBL] [Abstract][Full Text] [Related]
18. Roles of
Chiu SK; Huang LY; Chen H; Tsai YK; Liou CH; Lin JC; Siu LK; Chang FY; Yeh KM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533243
[TBL] [Abstract][Full Text] [Related]
19. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicenter study.
Casellas JM; Bantar C; Duret F;
J Chemother; 2007 Oct; 19(5):482-7. PubMed ID: 18077902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
